Richard J Benjamin Cerus Corp (CERS) insider trading activity

CERS Quotes by TradingView

Richard J Benjamin is Chief Medical Officer of CERUS CORP. Currently has a direct ownership of 734,799 shares of CERS, which is worth approximately $1.08 Million. The most recent transaction as insider was on Mar 07, 2025, when has been sold 26,139 shares (Common Stock) at a price of $1.5 per share, resulting in proceeds of $39,208. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 735K
67.76% 3M change
53.7% 12M change
Total Value Held $1.08 Million

Richard J Benjamin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2025
SELL
Open market or private sale
$39,208 $1.5 p/Share
26,139 Reduced 3.44%
734,799 Common Stock
Mar 06 2025
BUY
Grant, award, or other acquisition
-
366,565 Added 32.51%
760,938 Common Stock
Mar 04 2025
SELL
Open market or private sale
$9,752 $1.55 p/Share
6,292 Reduced 1.57%
394,373 Common Stock
Mar 03 2025
SELL
Open market or private sale
$80,981 $1.58 p/Share
51,254 Reduced 11.34%
400,665 Common Stock
Mar 03 2025
BUY
Exercise of conversion of derivative security
-
13,912 Added 2.99%
451,919 Common Stock
Aug 02 2024
SELL
Open market or private sale
$54,012 $2.5 p/Share
21,605 Reduced 4.7%
438,007 Common Stock
Mar 14 2024
SELL
Open market or private sale
$34,943 $1.97 p/Share
17,738 Reduced 3.72%
459,612 Common Stock
Mar 13 2024
SELL
Open market or private sale
$35,796 $2.06 p/Share
17,377 Reduced 3.51%
477,350 Common Stock
Mar 12 2024
BUY
Exercise of conversion of derivative security
-
16,666 Added 3.26%
494,727 Common Stock
Mar 08 2024
SELL
Open market or private sale
$70,507 $2.4 p/Share
29,378 Reduced 5.79%
478,061 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
160,000 Added 23.97%
507,439 Restricted Stock Unit
Mar 13 2023
SELL
Open market or private sale
$70,734 $2.79 p/Share
25,353 Reduced 6.8%
347,439 Common Stock
Mar 12 2023
BUY
Exercise of conversion of derivative security
-
40,127 Added 9.95%
363,186 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
160,000 Added 32.48%
332,665 Restricted Stock Unit
Aug 09 2022
SELL
Open market or private sale
$51,200 $5.12 p/Share
10,000 Reduced 5.47%
172,665 Common Stock
Mar 14 2022
SELL
Open market or private sale
$152,747 $5.04 p/Share
30,307 Reduced 14.23%
182,665 Common Stock
Mar 12 2022
BUY
Exercise of conversion of derivative security
-
84,437 Added 30.92%
188,647 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
52,500 Added 29.0%
128,535 Restricted Stock Unit
Nov 03 2021
SELL
Open market or private sale
$1,242,450 $7.53 p/Share
165,000 Reduced 68.45%
76,035 Common Stock
Nov 03 2021
BUY
Exercise of conversion of derivative security
$735,900 $4.46 p/Share
165,000 Added 60.51%
107,702 Common Stock
Mar 15 2021
SELL
Open market or private sale
$314,238 $6.37 p/Share
49,331 Reduced 39.35%
76,035 Common Stock
Mar 12 2021
BUY
Exercise of conversion of derivative security
-
83,603 Added 44.56%
104,024 Common Stock
RJB

Richard J Benjamin

Chief Medical Officer
Concord, CA

Track Institutional and Insider Activities on CERS

Follow CERUS CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CERS shares.

Notify only if

Insider Trading

Get notified when an Cerus Corp insider buys or sells CERS shares.

Notify only if

News

Receive news related to CERUS CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CERS